Yüklüyor......
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
Despite advances in prostate cancer diagnosis and management, morbidity from prostate cancer remains high. Approximately 20% of men present with advanced or metastatic disease, while 29,000 men continue to die of prostate cancer each year. Androgen deprivation therapy (ADT) has been the standard of...
Kaydedildi:
| Yayımlandı: | Transl Androl Urol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4708226/ https://ncbi.nlm.nih.gov/pubmed/26814148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-4683.2015.05.02 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|